| pubmed-article:21780650 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0005768 | lld:lifeskim |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0042666 | lld:lifeskim |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:21780650 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
| pubmed-article:21780650 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21780650 | pubmed:dateCreated | 2011-7-25 | lld:pubmed |
| pubmed-article:21780650 | pubmed:abstractText | To study effects of methotrexate on the titer of antibodies to mutated citrullinated vimentin (anti-MCV) and ascertain possibility of using this marker for control of treatment results and choice of individual effective dose of the drug. | lld:pubmed |
| pubmed-article:21780650 | pubmed:language | rus | lld:pubmed |
| pubmed-article:21780650 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21780650 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21780650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21780650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21780650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21780650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21780650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21780650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21780650 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21780650 | pubmed:issn | 0040-3660 | lld:pubmed |
| pubmed-article:21780650 | pubmed:author | pubmed-author:ShilkinaN PNP | lld:pubmed |
| pubmed-article:21780650 | pubmed:author | pubmed-author:VinogradovA... | lld:pubmed |
| pubmed-article:21780650 | pubmed:author | pubmed-author:BorisovaO LOL | lld:pubmed |
| pubmed-article:21780650 | pubmed:author | pubmed-author:VoroninaM SMS | lld:pubmed |
| pubmed-article:21780650 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21780650 | pubmed:volume | 83 | lld:pubmed |
| pubmed-article:21780650 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21780650 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21780650 | pubmed:pagination | 10-3 | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:meshHeading | pubmed-meshheading:21780650... | lld:pubmed |
| pubmed-article:21780650 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21780650 | pubmed:articleTitle | [Methotrexate-induced changes in the concentration of antibodies to mutaded citrullinated vimentin in blood serum of patients with rheumatoid arthritis]. | lld:pubmed |
| pubmed-article:21780650 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21780650 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:21780650 | pubmed:publicationType | English Abstract | lld:pubmed |
